Atlas Trials

Study to Evaluate the Benefits for the Patient Associated With the Treatment of Plaque Psoriasis With Apremilast After Other Systemic Treatment in Conditions of Clinical Practice in Spain

Clinical trial NCT03539419 · COMPLETED

Trial details

NCT number
NCT03539419
Sponsor
Amgen
Status
COMPLETED
Study type
OBSERVATIONAL
Psoriasis
Start date
2018-06-12
Primary completion
2019-11-02
Enrollment
153

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.